WASHINGTON, D.C. — May 2, 2016 — The Sabin Vaccine Institute (Sabin) today announced that Scott N. Wulfe, has joined its Board of Trustees. Mr. Wulfe is the managing partner of Vinson & Elkins LLP, an international law firm based in Houston. He maintains an active practice advising clients on mergers, acquisitions and divestitures, private equity investments and contests for corporate control.

“The Board is thrilled to welcome Mr. Wulfe, whose wide-ranging skills and experience in organizational matters, particularly in corporate governance, will be invaluable,” said Axel Hoos, M.D., Ph.D., chairman of the Sabin Board of Trustees. “His guidance and contributions will be particularly important as we assess new opportunities to leverage Sabin’s strengths in advocacy, communications and vaccine product development.”

Mr. Wulfe has represented many public companies, including several Fortune 500 companies, with respect to corporate governance advice and equity and debt offerings. His successful track record has earned him recognition as one of The Best Lawyers in America® in the specialties of Corporate Law, Mergers & Acquisitions Law and Venture Capital Law and as a Super Lawyer in Texas in the Mergers & Acquisitions field.

“I am excited to play a part in advancing Sabin’s mission through programs targeting vaccine-preventable and neglected tropical diseases,” said Mr. Wulfe. “I look forward to working with my fellow board members and the Sabin team, and learning more about how Sabin is helping to expand access to critical health interventions for the world’s most vulnerable communities.”

Mr. Wulfe serves as a trustee of The University of Texas Law School Foundation; a trustee and chair of the Risk Management & Insurance Committee of Texas Children’s Hospital; a governing director of the Houston Symphony; and board member of the Alley Theatre. He holds a juris doctor degree from the University of Texas at Austin School of Law.



About the Sabin Vaccine Institute

The Sabin Vaccine Institute (Sabin) is a non-profit, 501(c)(3) organization of scientists, researchers and advocates dedicated to reducing needless human suffering from vaccine-preventable and neglected tropical diseases (NTDs). Since its founding in 1993 in honor of Dr. Albert B. Sabin, the developer of the oral polio vaccine, Sabin has been at the forefront of global efforts to eliminate, prevent, and cure infectious and neglected tropical diseases.

Sabin develops new vaccines, advocates for increased use of existing vaccines and promotes expanded access to affordable medical treatments in collaboration with governments, academic institutions, scientists, medical professionals and other non-profit organizations. For more information, please visit www.sabin.org.

Media Contact
Kathryn McGrath
+1 (202) 683-1888